Emerging research suggest Retatrutide , a dual activator targeting both GLP-1 and another hormone, could provide a promising step forward for weight management . Early patient investigations have indicated considerable losses in abdominal mass , possibly surpassing existing body composition treatments. However , further study is needed to completel